68180-801 : Lapatinib 250 mg Oral Tablet
NDC: | 68180-801 |
Labeler: | Lupin Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Lapatinib |
Dosage Form: | Oral Tablet |
Application #: | ANDA203007 |
Rev. Date: |
NDC Package Codes:
- 68180-801-36: 150 TABLET IN 1 BOTTLE (68180‑801‑36)
Active Ingredients:
- Lapatinib Ditosylate
Dosage Strength:
- 250 mg
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Protein Kinase Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 68180-799Next: 68180-802 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.